ERK is one of the key mediators of epithelial-to-mesenchymal transition (EMT)53, and mesenchymal cells can survive better in adverse conditions, such as in detached conditions during embryonic development and carcinoma progression54,55. Here, MAPK1 is linked to carcinoma.